Squamous cell carcinoma of the bladder

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Squamous cell carcinoma (SCC) of the bladder is a rare bladder neoplasm.
• Understanding prognostic factors and optimal treatment is crucial for improving patient outcomes.

Purpose of the Study:

• To evaluate the survival rates and treatment efficacy for patients diagnosed with pure squamous cell carcinoma of the bladder.
• To identify the most effective treatment modality for this uncommon bladder cancer.

Main Methods:

• Retrospective analysis of medical and surgical pathological records from 46 patients with pure squamous cell carcinoma of the bladder.
• Evaluation of survival based on disease stage (limited to bladder, metastatic), depth of invasion (submucosal, muscular, perivesical, extravesical), and treatment modalities.

Main Results:

• Five-year survival rates varied significantly with invasion depth: 37% for submucosal/muscular invasion, 13% for perivesical invasion, and 0% for extravesical disease.
• Patients receiving preoperative radiation therapy followed by total cystectomy and urinary diversion demonstrated superior survival compared to other treatments.
• Nine patients presented with metastatic disease, with no long-term survival reported.

Conclusions:

• Preoperative radiation therapy followed by cystectomy and urinary diversion is recommended as the treatment of choice for pure squamous cell carcinoma of the bladder.
• Disease stage and depth of invasion are critical prognostic indicators for this bladder cancer.
• Multidisciplinary treatment strategies are essential for managing rare bladder neoplasms.